Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Mepolizumab on the Phenotype/Proteome/Transcriptome of Eosinophils in Severe Eosinophilic Asthma

NCT04641741 is registered in ClinicalTrials.gov with Hospital Clinico Universitario de Santiago as lead sponsor.

NCT NCT04641741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04641741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Mepolizumab on the Phenotype/Proteome/Transcriptome of Eosinophils in Severe Eosinophilic Asthma
Lead sponsor
Hospital Clinico Universitario de Santiago
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2021
Completion date
March 1, 2025
Enrollment
30 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, eosinophilic asthma